Emerging data are creating considerable anticipation surrounding this drug, specifically its ZPHC version. It is a novel injectable therapy designed to impact both pathways involved in appetite regulation and glucose control, potentially leading to substantial body loss for individuals battling against obesity . While preliminary trials suggest en